Touchstone Medical Imaging has agreed to pay a $3 million fine to the Office for Civil Rights (OCR) to settle potential Health Insurance Portability and Accountability (HIPAA) rule violations stemming from a large breach exposing patient health information.


The ARRS also presented Jonathan S. Lewin, MD, with the Gold Medal for 2019 during its annual meeting in Honolulu.

On May 22, more than 400 American College of Radiology (ACR) members will speak with their elected federal representatives to discuss four legislative priorities as part of Capitol Hill Advocacy Day at the 2019 ACR Annual Meeting.

Peptide radionuclide therapy (PRRT) demonstrated long-term effectiveness in patients with malignant neuroendocrine tumors, reported authors of a study published in the Journal of Nuclear Medicine.

The American Society of Breast Surgeons (ASBrS) has released new screening mammography guidelines based on a patient’s individual breast cancer risk profile. The American College of Radiology announced their support for the new recommendations.

The joint statement—published in Thyroid—was put out by American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging and the European Thyroid Association.

Targeted breast ultrasound should be the first-line imaging test in patients with palpable lumps after mastectomy. Mammography can help confirm suspected cases, but did not find any additional cancers.

“For CCTA to enter the mainstream of diagnostic clinical care, it is necessary to decrease observer variability and automate key parts of the interpretive process to manage the subjectivity, time-consuming nature, and variability of reader interpretation,” wrote authors of a new study published in the European Journal of Radiology.

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) have updated their clinical guidelines for adjuvant and salvage radiotherapy following prostatectomy.

Johns Hopkin’s researchers have created a PET-based approach that can direct cancer drugs to precise points in the brains of mice, according to a study published in the May 1 edition of the Journal of Nuclear Medicine. If proven effective in humans, the researchers believe their technique could help patients with difficult brain tumors, such as glioblastomas.

The Society of Interventional Radiology (SIR) and numerous other societies have endorsed prostatic artery embolization (PEA) as a safe and effective method to treat an enlarged prostate in certain patients.

The prospective single-center study, published April 30 in the American Journal of Roentgenology, adds more weight to the growing literature suggesting PSMA-11’s vital role in prostate cancer management.